Action Inyx (CE) - IYXI

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,000001

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,000001 Plage de 52 semaines 0,0001

Clôture Veille

0,000001

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

20 500

Volume financier

VWAP

Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Inyx Inc.

Coughlin Stoia Geller Rudman & Robbins LLP (?Coughlin Stoia?) (http://www.csgrr.com/cases/inyx/) today announced that a class...

Inyx Chairman & CEO Jack Kachkar Approved as Debtor-In-Possession Lender for Inyx Subsidiaries by Delaware Bankruptcy Court

NEW YORK, July 12 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI), reported that the company's Chairman & CEO, Jack Kachkar, M.D., yesterday was...

Buyout Group Reaffirms $3.01 Per Share All-Cash, Go-Private Offer For Inyx

NEW YORK, April 16 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche...

$3.01 Per Share All-Cash, Go-Private Offer for Inyx

NEW YORK, March 26 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on niche drug...

Inyx Reports Update on Corporate Matters

NEW YORK, March 19 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on niche drug...

Inyx's Ashton Subsidiary to Manufacture and Package Prescription Product for Acorus Therapeutics

NEW YORK, Jan. 31 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche...

Inyx Reports Update on Corporate Matters

NEW YORK, Jan. 25 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche...

Inyx and BioProgress Form Strategic Collaboration

NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche...

Generex Biotechnology Selects Inyx to Produce Glucose RapidSpray(TM) for Worldwide Markets

NEW YORK, Dec. 7 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in treating metabolic diseases via drug...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	20500	1.0E-6	CS
26	-9.9E-5	-99	0.0001	0.0001	1.0E-6	10275	1.0E-6	CS
52	-9.9E-5	-99	0.0001	0.0001	1.0E-6	5122	1.174E-5	CS
156	0	0	1.0E-6	0.0001	1.0E-6	44301	9.353E-5	CS
260	-0.002949	-99.9661016949	0.00295	0.0124	1.0E-6	133014	0.0039402	CS

IYXI - Frequently Asked Questions (FAQ)

What is the current Inyx (CE) share price?

The current share price of Inyx (CE) is US$ 0,000001

What is the 1 year trading range for Inyx (CE) share price?

Inyx (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MNIIManati Inds Inc (CE)	US$ 0,25 (24 999 900,00%)	100
GOOXFGivot Olam Oil Exploration LP (CE)	US$ 0,05 (4 999 900,00%)	1 000
EWGFFEat Well Investment Group Inc (CE)	US$ 0,04 (3 999 900,00%)	510
BETSFBit Brother Ltd (CE)	US$ 0,0002 (19 900,00%)	262
SUNCSuncast Solar Energy Inc (CE)	US$ 0,0001 (9 900,00%)	71,97k
ATHXQAthersys Inc New (CE)	US$ 0,000001 (-99,90%)	4,81k
STTOSITO Mobile Ltd (CE)	US$ 0,0002 (-99,90%)	278
ZHCLFZenith Capital Corporation (CE)	US$ 0,0001 (-99,80%)	10,22k
SHMPNaturalShrimp Incorporated (CE)	US$ 0,000001 (-99,80%)	84,27k
VAXXVaxxinity Inc (CE)	US$ 0,0001 (-99,80%)	4,52k
HMBLHUMBL Inc (PK)	US$ 0,0004 (0,00%)	689,11M
RONNRonn Motor Group Inc (PK)	US$ 0,0002 (0,00%)	467,39M
IJJPIJJ Corporation (PK)	US$ 0,0001 (-60,00%)	263,04M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0,0022 (-4,35%)	147,35M
DPLSDarkPulse Inc (PK)	US$ 0,0007 (0,00%)	132,64M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Inyx Inc (CE) (IYXI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

IYXI Dernières nouvelles

Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Inyx Inc.

Inyx Chairman & CEO Jack Kachkar Approved as Debtor-In-Possession Lender for Inyx Subsidiaries by Delaware Bankruptcy Court

Buyout Group Reaffirms $3.01 Per Share All-Cash, Go-Private Offer For Inyx

$3.01 Per Share All-Cash, Go-Private Offer for Inyx

Inyx Reports Update on Corporate Matters

Inyx's Ashton Subsidiary to Manufacture and Package Prescription Product for Acorus Therapeutics

Inyx Reports Update on Corporate Matters

Inyx and BioProgress Form Strategic Collaboration

Generex Biotechnology Selects Inyx to Produce Glucose RapidSpray(TM) for Worldwide Markets

IYXI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Inyx Inc (CE) (IYXI) Cours

Inyx Inc (CE) (IYXI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

IYXI Dernières nouvelles

Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Inyx Inc.

Inyx Chairman & CEO Jack Kachkar Approved as Debtor-In-Possession Lender for Inyx Subsidiaries by Delaware Bankruptcy Court

Buyout Group Reaffirms $3.01 Per Share All-Cash, Go-Private Offer For Inyx

$3.01 Per Share All-Cash, Go-Private Offer for Inyx

Inyx Reports Update on Corporate Matters

Inyx's Ashton Subsidiary to Manufacture and Package Prescription Product for Acorus Therapeutics

Inyx Reports Update on Corporate Matters

Inyx and BioProgress Form Strategic Collaboration

Generex Biotechnology Selects Inyx to Produce Glucose RapidSpray(TM) for Worldwide Markets

IYXI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités